Map courtesy of IUPUI Polis Center

Regenstrief Institute COVID-19 Dashboard

US COVID-19 Cases Map

Serious Illness Care Program COVID-19
Response Toolkit: Ariandne Labs

IUSM Library COVID-19
Research Guide

IU Psychiatry Mental
Health Resource Library

IUPUI COVID-19
ECHO Registration

Johns Hopkins COVID-19
POC Guide

NCBI LitCovid
Literature Hub

Update on Medicaid Policy Changes (FSSA)
In response to the COVID-19 public health emergency, some policy and program changes have been made to help ensure members in managed care programs (Healthy Indiana Plan, Hoosier Care Connect, Hoosier Healthwise) as well as traditional Medicaid members are able to maintain continuous coverage in this critical time.

Executive Order 20-37 – FACE COVERING REQUIREMENT
As of Monday, July 27, 2020, Governor Holcomb’s executive order requires that all Hoosiers wear face coverings in most public settings. Cloth masks and other non-medical face coverings are recommended for all people, both public and private, in interacting in their workplaces and community, such as shopping. The only exception is children younger than 2 years of age; they should not have face coverings, according to the CDC.

ISDH COVID-19 Page
Indiana FSSA COVID-19 Page

WHO Situation Report (WHO)
Daily updates from the World Health Organization on the COVID-19 Pandemic across the globe. This document also provides surveillance data and WHO objectives during the pandemic.

CDC’s Diagnostic Multiplex Assay for Flu and COVID-19 and Supplies (CDC)
The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for this test on July 2, 2020. Further details on ordering and materials are on the webpage.

COVIDView Weekly Summary (CDC)
Nationally, the percentage of laboratory tests positive for SARS-CoV-2 remained stable from week 29 to week 30 but increased in six of ten HHS regions. Weekly hospitalization rates and mortality attributed to COVID-19 declined during week 30 but may change as more data for admissions and deaths occurring during the most recent weeks are received. Mortality attributed to COVID-19 remains above the epidemic threshold.

Forecasts of Total Deaths (CDC)
This week’s national ensemble forecast predicts that weekly reports of new COVID-19 deaths may increase over the next month, with 5,000 to 11,000 new deaths reported during the week ending August 22. The ensemble forecast predicts that 168,000 to 182,000 total COVID-19 deaths will be reported by August 22.

WHO COVID-19 Page
CDC COVID-19 Page

These documents were prepared by teams of research librarians and faculty experts in response to specific questions posed by individuals involved in Indiana’s frontline COVID-19 response. They summarize information that frontline responders may find useful. Please note that information is current for the dates specified. New studies, priorities and literature are being published daily, and best practices are rapidly evolving. These documents do not represent clinical guidelines, standard operating procedures, or the opinions or positions of FSSA.

• What is the evidence base for viral testing of wastewater to inform COVID-19 mitigation and containment efforts?
• What is known about whether and how the SARS-CoV-2 virus may mutate?
• What is the latest evidence regarding the effectiveness of mask use in preventing COVID-19 transmission?
• What symptoms are associated with SARS CoV-2? What is the prevalence of those symptoms among people who test positive? How frequently do people experience 1 symptom, 2 symptoms, 3 symptoms, more than 3 symptoms?

wisein@iu.edu | 317-274-7155